15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia. by Ulfarsson, M O et al.
OPEN
ORIGINAL ARTICLE
15q11.2 CNV affects cognitive, structural and functional
correlates of dyslexia and dyscalculia
MO Ulfarsson1,2, GB Walters1, O Gustafsson1, S Steinberg1, A Silva3, OM Doyle4, M Brammer4, DF Gudbjartsson1,5, S Arnarsdottir1,6,
GA Jonsdottir1, RS Gisladottir1, G Bjornsdottir1, H Helgason1,2, LM Ellingsen2, JG Halldorsson7, E Saemundsen7,8, B Stefansdottir1,
L Jonsson1, VK Eiriksdottir1, GR Eiriksdottir1, GH Johannesdottir1, U Unnsteinsdottir1, B Jonsdottir9, BB Magnusdottir6,10, P Sulem1,
U Thorsteinsdottir1,7, E Sigurdsson6,7, D Brandeis11,12, A Meyer-Lindenberg12, H Stefansson1 and K Stefansson1,7
Several copy number variants have been associated with neuropsychiatric disorders and these variants have been shown to also
inﬂuence cognitive abilities in carriers unaffected by psychiatric disorders. Previously, we associated the 15q11.2(BP1–BP2) deletion
with speciﬁc learning disabilities and a larger corpus callosum. Here we investigate, in a much larger sample, the effect of the
15q11.2(BP1–BP2) deletion on cognitive, structural and functional correlates of dyslexia and dyscalculia. We report that the deletion
confers greatest risk of the combined phenotype of dyslexia and dyscalculia. We also show that the deletion associates with a
smaller left fusiform gyrus. Moreover, tailored functional magnetic resonance imaging experiments using phonological lexical
decision and multiplication veriﬁcation tasks demonstrate altered activation in the left fusiform and the left angular gyri in carriers.
Thus, by using convergent evidence from neuropsychological testing, and structural and functional neuroimaging, we show that
the 15q11.2(BP1–BP2) deletion affects cognitive, structural and functional correlates of both dyslexia and dyscalculia.
Translational Psychiatry (2017) 7, e1109; doi:10.1038/tp.2017.77; published online 25 April 2017
INTRODUCTION
Speciﬁc learning disorders, such as dyslexia (DLX) and dyscalculia
(DC), are challenging phenotypes to disentangle. DLX and DC refer
to neurodevelopmental disorders manifested in learning difﬁcul-
ties with impairment in acquiring skills in reading and arithmetic,
respectively, not due to intellectual disabilities or other develop-
mental or neurological disorders.1 Despite being highly heritable,
h2 = 0.52 for DLX and 0.61 for DC,2 genome-wide association
studies have failed to uncover sequence variants conferring risk of
these speciﬁc learning disorders.3,4 Hence, larger genome-wide
scans are needed to unravel how a conﬂuence of rare and
common sequence variants confer risk and which biological
pathways are affected.
Prevalence of DLX and DC range from 4 to 7% depending on
the criteria used.5 These learning disorders co-occur much more
frequently than expected by chance; the comorbidity rate has
been estimated as high as 40%.6 Although DLX and DC occur
more often separate from each other, and largely distinct brain
systems handle reading and mathematics, certain brain regions
are important for both. Regions that have been associated with
both disorders include the fusiform gyrus (BA37), which lies below
the lingual and parahippocampal gyri and above the inferior
temporal gyrus, as well as the angular gyrus (BA39), which is
located in the posterior part of the inferior parietal lobe. The
fusiform gyrus is thought to be an important structure for
discriminating between and within categories of objects and
includes the left hemisphere ‘visual word form area’. Dysfunction
in these areas can lead to reading and/or math difﬁculties; the left
fusiform gyrus has been shown to have less gray matter density
and activation in individuals diagnosed with DLX.7 The angular
gyrus8 has been shown to associate with high-level language and
mathematical tasks, such as arithmetic fact retrieval.9
Some rare copy number variants (CNVs) are associated with
neuropsychiatric disorders. Although little is known about how
these high-impact variants confer risk of disease, they provide a
biologically deﬁned entry point for investigations into the
mechanisms of brain function. These CNVs impact cognitive
functions and learning and are probably the strongest identiﬁable
factors contributing to the disease in affected carriers.10–12 An
example is the 15q11.2(BP1–BP2) deletion that confers risk of
neuropsychiatric disorders including speciﬁc learning difﬁculties.
We have previously described the impact of the 15q11.2(BP1–BP2)
deletion on cognitive abilities assessed by neuropsychological
tests.11 Deletion carriers show modest impairments in most
cognitive domains and the deletion confers high risk for DLX
and DC. Here we investigate the effect of the 15q11.2(BP1–BP2)
deletion on cognition, brain structures and functions of deletion
carriers in a larger sample. Through neuropsychological testing,
we establish that the cognitive proﬁle of the deletion carriers is
similar to the cognitive proﬁle of the combined phenotype of
dyslexia and dyscalculia. By using magnetic resonance imaging
(MRI) and functional MRI (fMRI), we show that the deletion affects
structural and functional correlates of DLX and DC.
Phenotypic heterogeneity, caused by many different biochem-
ical perturbations, complicates the search for sequence variants
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conferring risk of DLX and DC. Here we focus on the impact
conferred by the 15q11.2(BP1–BP2) deletion and show that the
sequence variant confers risks of both DLX and DC and the carriers
have cognitive, structural and functional aberrations that are
considered to be correlates of both conditions.
MATERIALS AND METHODS
Participants
Subjects carrying the 15q11.2(BP1–BP2) deletion, and controls not carrying
CNVs associated with psychiatric disorders (NoCNV), were recruited from a
large genotyped sample of approximately 160 000 subjects representing
half of the Icelandic population. Only subjects aged between 18 and 65
were included in this study. Subjects were excluded: if they had ICD-10 or
DSM-IV diagnoses for schizophrenia, schizoaffective or bipolar disorder; if
they were diagnosed with autism, intellectual disability or developmental
delay at the State Diagnostic and Counselling Centre of Iceland serving
children and adolescents with a disability; if they met psychoses criteria on
the MINI13 interview; if they were diagnosed with schizophrenia,
schizoaffective, bipolar disorder, autism, intellectual disability or develop-
mental delay according to self-reports (or reports from parents); if they
were using antipsychotic medication. In the neuroimaging experiment, we
used a subset of the NoCNV group of subjects without any large CNVs
(PopCtrl). Supplementary Table 1 shows the population characteristics for
subjects participating in the neuroimaging experiments. All the partici-
pants signed informed consent approved by the National Bioethics
Committee of Iceland.
Cognitive phenotyping
A total of 71 subjects carrying the 15q11.2(BP1–BP2) deletion in the
absence of a schizophrenia, bipolar disorder, autism or intellectual
disability diagnosis were recruited along with 643 controls not carrying
CNVs associated with psychiatric disorders (NoCNV). Participants were
assessed with a battery of neuropsychological tests measuring cognitive
traits, the global assessment of functioning scale and self-reported
questionnaires on reading (adult reading history questionnaire, ARHQ)
and mathematics (adult mathematical history questionnaire, AMHQ).
Psychologists and others phenotyping the study subjects were blind to
the genotype. Large lists of CNV-carriers and non-carriers were sent to a
clinic overseeing the phenotyping. Identiﬁers were encrypted and sent
back to researchers working on the genetic data. A detailed deﬁnition of
the tests and questionnaires is given in a previous study (see also
Figure 1).11 Supplementary Table 2 shows the sample sizes for the tests
and questionnaires. To investigate the deletion group with respect to
Figure 1. Association of the 15q11.2(BP1–BP2) deletion group and subgroups of NoCNV with cognitive traits, GAF, ARHQ, AMHQ and
functional MRI test scores. (a) Average standardized scores for 15q11.2(BP1–BP2) deletion, DLX&DC and NoCNV without (w/o) learning
difﬁculties. (b) Average standardized scores for DLXonly, DConly and NoCNV w/o learning difﬁculties. (c) Mean accuracy for fMRI phonological
lexical decision tasks (words) and multiplication veriﬁcation tasks (mult) for 15q11.2(BP1–BP2) deletion, DLXonly, DConly, DLX&DC and NoCNV.
The tests are verbal IQ (V-IQ); performance IQ (P-IQ); logical memory I and II (LM I and II); letter ﬂuency (LF); category ﬂuency (CF); Stroop (the
difference between the time it takes to name the color of the ink of a word that is actually the name of another color and to name the color of
colorpads); trail making test (TMT), TMT trail B–TMT trail A; perseverative errors in the Wisconsin card sorting test (Pers. Err); spatial working
memory (SWM); rapid visual information processing (RVIP); TMT trail A (TMT-A); Str-bl (Stroop: time it takes to read the names of colors written
in black ink); global assessment of function (GAF); adult reading history questionnaire (ARHQ); adult mathematical history questionnaire
(AMHQ). Word experiment: orthographic familiar forms of Icelandic nouns (W); phonologically correct but orthographically unfamiliar forms
of the same word (PH); phonologically and orthographically unfamiliar forms (PW); false fonts (FF). Multiplication experiment: correct equation
(C); incorrect equation (NC); false equation (F). See previous study11 for more information about tests in a and b, and the functional MRI
section below for more information about tests in c. Error bars represent standard error. Impairment is in s.d. units. The sample size given in
the ﬁgure legend for a and b refer to the number of subjects with available scores. Some individual scores are missing. The sample size for
each test is given in Supplementary Table 2. CNV, copy number variation; DC, dyscalculic; DConly, dyscalculic but not dyslexic; DLX, dyslexic;
DLX&DC, dyslexic and dyscalculic; DLXonly, dyslexic but not dyscalculic; IQ, intelligence quotient; MRI, magnetic resonance imaging.
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reading and math, the NoCNV group was further separated into six
subgroups deﬁned by using a score greater than 0.43 on the ARHQ,14 and
a score greater than 12 on the AMHQ11 as a surrogate for dyslexia and
dyscalculia, respectively. These subgroups contain (i) 80 dyslexic but not
dyscalculic (DLXonly), (ii) 69 dyscalculic but not dyslexic (DConly), (iii) 42
dyslexic and dyscalculic (DLX&DC), (iv) 452 NoCNV without speciﬁc
learning difﬁculties, (v) 123 dyslexic (without regard to the dyscalculic
status) (DLX), (vi) 111 dyscalculic (without regard to the dyslexic status).
Supplementary Table 3 presents the carrier status and the number of
individuals in each subgroup.
Statistical analysis of cognitive traits
The scores from each cognitive test or questionnaire were inverse normally
transformed and then adjusted for gender, age at testing and where
indicated, intelligence quotient (IQ) based on data from controls only. The
scores were shifted and scaled so that controls had a mean of 0 and a
standard deviation of 1, and also arranged so that higher scores indicated
greater impairment. Fisher’s exact test and the DLX and DC subgroup
information in Supplementary Table 3 was used to estimate the deletions’
risk of DLX, DC and DLX&DC. A result was judged as signiﬁcant when the P-
value was less than 0.05 Bonferroni corrected for the number of cognitive
tests or questionnaires.
Structural MRI data acquisition
The subjects listed in Supplementary Table 1 were scanned using an MRI
scanner (1.5 T Philips Achieva, Philips Medical Systems, Eindhoven,
Netherlands). The scans were performed with a three-dimensional fast
T1-weighted gradient echo sequence (TR = 8.6 ms, TE = 4 ms, ﬂip angle = 8
degrees, slice thickness 1.2 mm, matrix = 192× 192, ﬁeld of
view=240× 240 mm). This MRI protocol was selected as it yields good
contrast between white matter (WM), gray matter (GM) and cerebrospinal
ﬂuid. Quality control consisted of visual inspection as well as a test of
homogeneity of the image covariance, which is a part of the voxel-based
morphometry (VBM) protocol described below. A total of 716 participants
were scanned with 707 subjects passing quality checks.
Voxel-based morphometry
By using VBM,15,16 we analyzed the allele dose-dependent effect of CNV on
white and gray matter tissue across subjects, while controlling for age and
gender. VBM is a technique that allows investigation of regional
differences in the brain anatomy. In this study, the T1-weighted structural
brain MRIs were analyzed using VBM as implemented by the VBM8
software (http://dbm.neuro.uni-jena.de (version r351)), which is integrated
into the SPM8 software (Wellcome Department of Cognitive Neurology,
Institute of Neurology, London, UK, (http://www.ﬁl.ion.ucl.ac.uk/spm))
implemented in MATLAB R2013b (Mathworks, Sherborn, MA, USA). Brieﬂy,
each T1-weighted structural brain MRI is tissue-segmented into WM, GM
and cerebrospinal ﬂuid images, which are then registered to the MNI
(Montreal Neurological Institute)17 space using an afﬁne transformation.
After the tissue segmentation step, a spatial normalization step was
performed where each tissue segment is brought into a common
stereotactic space. This step uses the DARTEL algorithm18 and a brain
template derived from 550 healthy control subjects in the IXI-database
(http://www.brain-development.org). Finally, the maps from the normal-
ization step were modulated, that is, intensity-corrected for local volume
changes during the spatial normalization. To accommodate for noise and
registration errors, the modulated maps were smoothed with a 12 mm full-
width half-maximum Gaussian ﬁlter.
Statistical analysis of the structural brain MRI data
Multiple regression analysis was used to test carrier status effects on brain
volume on a voxel-wise basis using SPM8. We examined regions
throughout the entirety of the brain for volume differences using the
model:
Volume ¼ ðbaselineÞβ0+ðcarrierstatus)β1+ðageÞβ2+ðgenderÞβ3+noise:
The carrier status was modeled by using a regressor coding deletion as 0,
PopCTRL as 1 and duplication as 2. Age and gender were added in the
statistical model as covariates of no interest. Furthermore, we inspected
the effects of adding intracranial volume as a covariate of no interest but it
had minor effect on the results and did not change the conclusions. The
carrier status effects were tested using one-sided t-tests and the voxel-wise
effects on gray and white matter volume were reported as signiﬁcant
when a whole-brain family-wise error-corrected P-value was less than 0.05.
Owing to the intrinsic spatial smoothness of the data, the Bonferroni
correction procedure is overly conservative. Therefore, we use the random
ﬁeld theory19,20 correction method as implemented in the SPM8 toolbox to
correct for multiple comparisons.
Functional MRI
The subjects listed in Supplementary Table 1 participated in two fMRI
experiments, the ﬁrst involving a phonological lexical decision task (word
experiment), and the second involving a multiplication veriﬁcation task
(multiplication experiment).
Functional MRI acquisition
The data were collected using a 1.5 T Philips Achieva MRI scanner. Two
hundred and sixty-ﬁve volumes (185 volumes in the short version; see
below) and 215 volumes were acquired for the words and multiplication
experiments, respectively. In both experiments, 28 axial brain slices were
acquired using an echo planar imaging pulse sequence (TR = 3 s;
TE = 55 ms; image matrix = 64 × 64; voxel size = 3.75 × 3.75 × 5 mm3; ﬂip
angle = 90°; slice order = ascending, sequential; coverage=whole brain).
fMRI word experiment
During the fMRI scanning, the participants were asked to decide
whether a visually presented letter string sounded like a real word
or not. The experimental design follows a previous fMRI study21 closely
with the main difference being that it was modiﬁed for Icelandic
native speakers. There were two versions of the experiment: the long
version and the short version. In the long version, there were 176
stimuli, lasting one second each, consisting of four types: 44 orthographi-
cally familiar forms of Icelandic nouns (W), 44 pseudohomophones that
were phonologically correct but an orthographically unfamiliar form of the
same word (PH), phonologically and orthographically unfamiliar forms
(PW) and 44 false fonts (FF). In addition, there were 59 null events where
only the ﬁxation cross was presented. In the short version, there were 120
stimuli, 30 for each stimuli type (W, PH, PW and FF) and 43 null events.
Subjects were excluded from the analysis if they (i) exceeded a priori
maximum movement criterion (±3 mm translation or ± 3° rotation), (ii)
performed poorly in the phonological lexical decision task (o60%
accuracy in one or more stimuli type) or (iii) had poor quality MR data.
A total of 337 participants were scanned with 284 subjects passing quality
checks.
fMRI multiplication paradigm
During fMRI scanning, the participants were asked to verify whether a
visually presented multiplication equation was correct or not. There were
132 stimuli consisting of three types: 44 correct (C) multiplication
equations, for example, 5 × 9= 45; 44 incorrect (NC) multiplication
equations, for example, 6 × 6 = 21; 44 false (F) equations, for example, 9
q 4 = lv. The correct equations were selected from the 10 × 10 multi-
plication table. Subjects were excluded from the analysis according to the
same exclusion criteria as in the word experiment. A total of 117
participants were scanned with 110 subjects passing quality checks.
Statistical analysis of the fMRI data
The data were analyzed using SPM12. The statistical analysis described
here is only for the word experiment, the analysis was similarly performed
for the multiplication test. The data were ﬁrst realigned to the mean, using
a rigid model, followed by a slice timing correction. After that, the mean
image of each echo planar imaging time series was spatially normalized to
the SPM's MNI152 template. The images were then spatially resampled to
2 × 2× 2 mm3. Finally, the images were spatially smoothed using a 9 mm
full-width at half-maximum Gaussian kernel.
A two-stage model was used for statistical analysis assuming a mixed-
effect design. In the ﬁrst stage, event types representing the correct
responses for each stimuli type (W, PH, PW and FF) were modeled using
the standard SPM hemodynamic function with its temporal derivative. The
incorrect stimuli responses were modeled the same way and were also
included in the model. The model also included six movement regressors
from the realignment step.
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In the second stage, the following contrasts W, PH, PW, FF, W vs FF, FF vs
W, PH vs W, W vs PH, W vs PW and PW vs W, were tested using a one-sided
t-test using the following multiple regression model:
Contrast ¼ ðbaselineÞβ0+ðcarrier status)β1+ðageÞβ2+ðgenderÞβ3+ðscan lengthÞβ4+noise;
where the carrier status was modeled using a regressor coding deletion as
0, PopCTRL as 1 and duplication as 2, and the scan length was modeled by
coding the long-word version with 1 and the short-word version with 2;
scan length was not included as a covariate in the regression model for the
multiplication test. Given our a priori hypothesis and the brain-wide
signiﬁcant results from the structural analysis, we constructed a mask using
the Automatic Anatomic Labeling atlas22 consisting of the left fusiform
gyrus, left parahippocampal gyrus, inferior parietial lobule, angular gyrus,
and supramarginal gyrus. We reported voxel-wise carrier status effects on
the contrasts signiﬁcant when the family-wise error-corrected19,20 (within
this mask) P-value was less than 0.05. In the case of the multiplication test,
the contrasts C, F, F vs C, C vs F, NC, NC vs C, C vs NC, F vs NC and NC vs F
were analysed.
Correlations between the brain imaging and the cognitive
phenotypes
The Pearson’s correlation measure between each of the cognitive tests/
questionnaire score in Figure 1 and the brain imaging phenotype in
Table 1 for both the NoCNV group and the 15q11.2(BP1–BP2) deletion
group was computed. All the scores were corrected for gender and age
before the correlation was computed. The brain phenotypes were the raw
volume scores (for the VBM data) and contrast scores (for the fMRI data) at
the locations indicated in Table 1. A result was judged as signiﬁcant when
the P-value was less than 0.05 Bonferroni corrected for the number of
correlations computed.
RESULTS
Neuropsychology
The same neuropsychiatric CNV often confers risk of a range of
neurodevelopmental phenotypes including schizophrenia, autism,
intellectual disability, attention deﬁcit hyperactivity disorder and
epilepsy. The 15q11.2(BP1–BP2) deletion has been associated with
schizophrenia as well as speciﬁc learning disorders.11
Our previous results show that 15q11.2(BP1–BP2) deletion
carriers unaffected by neuropsychiatric disorders do perform
worse on neuropsychological tests and are more likely to suffer
from speciﬁc learning disorders than population controls.11 Hence,
when learning difﬁculties are considered, the deletion is likely to
be fully penetrant although the expressivity may vary substan-
tially. The deletion confers high risk of DLX (odds ratio = 3.0,
P= 2.2 × 10− 4) and DC (odds ratio = 3.4, P = 4.9 × 10− 5) when
using a score greater than 0.43 on the ARHQ14 and a score greater
than 12 on the AMHQ11 as a surrogate for dyslexia and dyscalculia,
respectively. The deletion confers a greater risk when considering
the comorbid phenotype DLX&DC (odds ratio = 4.4, P= 1.3 × 10− 4).
Considering all the tests in Figure 1a except for the ARHQ and
the AMHQ tests, it can be seen that the deletion group and the
DLX&DC group have a similar proﬁle (Spearman’s correlation
between mean proﬁle scores = 0.58, P= 0.042). The impairments
(again excluding the ARHQ and the AMHQ tests) present in the
DLXonly, and the DConly phenotypes combine additively to
produce the impairments in the DLX&DC phenotype (Spearman’s
correlation between the sum of the DLXonly and DConly means
and the DLX&DC means = 0.63, P= 0.023). The DLXonly and
DConly groups (Figure 1b) clearly have different proﬁles, especially
with regards to the IQ scores, perseverative errors in the Wisconsin
card sorting test, spatial working memory and trail making test A.
The deletion group was compared with the combined group of
DLXonly, DConly, DLX&DC and NoCNV without learning difﬁcul-
ties. The largest impairment is observed on the ARHQ (0.58 s.d.,
P= 1.5 × 10− 4) and the AMHQ scores (0.75 s.d., P= 7.4 × 10− 7).
However, the deletion group also shows impairment on other
scores. When the scores are corrected for performance IQ and
verbal IQ, the impairments on ARHQ (0.44 s.d., P= 0.0044), and
AMHQ (0.64 s.d., P= 3.5 × 10− 5) remain, whereas the impairments
measured by the other scores are not signiﬁcant compared with a
Bonferroni threshold of P= 0.05/30 = 0.0017 accounting for the 15
tests with and without the IQ adjustment.
The deletion group shows impairments in reading and
mathematics, based on the phonological lexical decision task
(PW) and the multiplication task (NC; see Figure 1c for a deﬁnition)
used to assess how well carriers recognize words and understand
mathematical equations. The deletion carriers perform worse on
both tests than controls (Figure 1c).
Table 1. Carrier status-dependent functional, gray and white matter volume changes
Hemisphere MNI coordinates
(x, y, z)
Effect (%)
95% CI
P-value
(corrected)
Brodmann
area
sMRI: gray matter
Fusiform gyrus Left (−35, − 36, − 15) +3.0 (2.9, 3.1) 0.045 BA37
Superior occipital Left (−22, − 78, 24) − 4.8 (−5.0, − 4.6 ) 0.016 BA19
Superior frontal Right (20, 30, 52) − 5.0 (−5.2, 4.8 ) 0.016 BA8
sMRI: white matter
Cerebellum cruz 1 Right (28, − 72, − 32) +7.7 (7.6, 7.9) 6.84 × 10− 5
Paracentral lobule Right (10, − 30, 54) +4.6 (4.5, 4.7) 6.93 × 10− 4
Superior temporal Left (−52, − 12, 13) +5.0 (4.5, 5.1) 1.94 × 10− 3
Anterior corpus callosum NA (4, 0, 22) − 4.6 (−4.7, − 4.5) 6.84 × 10− 4
Amygdala Right (26, 2, − 17) − 4.7 (−4.8, − 4.6) 5.57 × 10− 3
fMRI word paradigm: PW vs W
Fusiform gyrus Left (−28, − 36, − 14) +68.2 (63.7, 72.8) 0.007a BA37
fMRI multiplication paradigm: C vs F
Angular gyrus Left (−50, − 66, 24) +87.2 (80.8, 93.8) 2.08 × 10−4a BA39
Abbreviations: C, correct equation; CI, conﬁdence interval; F, false equation; fMRI, functional MRI; MNI, Montreal Neurological Institute; MRI, magnetic
resonance imaging; NA, not available; PW, phonologically and orthographically unfamiliar forms; sMRI, structural brain MRI; W, orthographic familiar forms of
Icelandic nouns. aP-values marked with a are corrected with respect to a region of interest (the left occipito-temporal lobe and the left parietal lobe). All the
brain regions highlighted in Figures 1–3 are listed here. The sample sizes are n= 707 for sMRI, n= 284 for the fMRI word paradigm and n= 110 for the fMRI
multiplication paradigm. The effects are calculated as (carrier status effect−mean)/|mean|.
Impact of 15q11.2 CNV on dyslexia and dyscalculia
MO Ulfarsson et al
4
Translational Psychiatry (2017), 1 – 8
Subjects carrying 15q11.2(BP1–BP2) duplications were also
investigated with respect to the aforementioned tests. No
signiﬁcant impairments in the 15 tests presented in Figures 1a
and b were detected in the 15q11.2(BP1–BP2) duplication carriers
as compared with the rest of the NoCNV group.
Structural MRI phenotypes
We obtained structural brain MRI of 51 carriers of the 15q11.2
(BP1–BP2) deletion not diagnosed with deﬁned neuropsychiatric
disorders, 104 carriers of the reciprocal duplication and 552
controls not carrying CNVs associated with psychiatric disorders
and without large CNVs (PopCtrl).
We examined regions throughout the entirety of the brain and
analysed the result using whole-brain family-wise error multiple
comparison correction. For both GM and WM, the carriers of a
deletion vs duplication showed mirrored effects, that is, the
deletion carriers show opposite changes to the duplication carriers
(Supplementary Figures 1 and 2). The 15q11.2(BP1–BP2) deletion
carriers have less GM volume in the left fusiform gyrus extending
into the parahippocampal gyrus, and greater GM volume in the
superior occipital gyrus (which is a part of the visual association
area) and the superior frontal regions (Figure 2 and Table 1). The
area in the superior frontal gyri has been implicated in visual
attention.23 The deletion carriers have less WM volume in the right
cerebellum, the right paracentral lobule and the left superior
temporal lobe. On the other hand, the deletion carriers have
greater WM volume in the anterior corpus callosum and the right
amygdala (Figure 3 and Table 1). We observed a signiﬁcant
interaction between carrier status of the CNV and gender in the
right caudate nucleus (Supplementary Figure 3), that is, the female
deletion carriers have greater GM volume than female duplication
carriers, and on the other hand, male deletion carriers have less
GM volume than the male duplication carriers (Supplementary
Figure 4).
Functional MRI phenotypes
Based on our a priori hypothesis, we performed two fMRI
experiments: a phonological lexical decision task (word experi-
ment) and a multiplication veriﬁcation task (multiplication
experiment). Given the results of the structural analysis, we
restricted our fMRI analysis to the left occipito-temporal cortex
and the left parietal lobe.
A total of twenty nine 15q11.2(BP1–BP2) deletion carriers, 191
PopCtrl subjects and 60 duplication carriers took part in the word
experiment. The participants were asked to decide whether a
visually presented letter string sounded like a real word or not.
There were four types of letter strings: (i) orthographically familiar
forms of Icelandic nouns (W), (ii) pseudohomophones that were
phonologically correct but orthographically unfamiliar forms of
the same words (PH), (iii) pseudowords that were phonologically
and orthographically unfamiliar forms (PW) and (iv) false fonts (FF).
The experimental design follows that of van der Mark et al.,21 with
the main difference being the translation to Icelandic.
As with the structural MRI results, the effect of deletion vs
duplication carrier status on brain volumes was mirrored
(Supplementary Figure 5). The results show that the deletion
carriers have less PW vs W contrast in the left fusiform gyrus
(Figure 4, Table 1). A previous report demonstrated the presence
of phonological and orthographic familiarity effects in non-
dyslexic children. Non-dyslexic children showed higher activation
for unfamiliar (PH and PW) rather than familiar (W) word-forms,
whereas this effect was absent in children with dyslexia.21 The
results presented here are in line with this, showing that the
phonological/orthographic familiarity effect is decreased in the
left fusiform gyrus of deletion carriers.
The multiplication experiment was performed on 18 deletion
carriers, 40 PopCTRL and 52 duplication carriers. They were asked
to determine whether a visually presented multiplication equation
Figure 2. The effect of the CNV carrier status (deletion, PopCtrl, duplication) on gray matter volume difference. The T-scores for the CNV carrier
status are displayed where ﬁndings are highlighted in red or blue if Po0.001 with red indicating less gray matter volume for the 15q11.2
(BP1–BP2) deletion carriers, and blue indicating greater volume. The ﬁrst three ﬁgures are sagittal slices while the last ﬁgure shows a coronal
slice where the location of the sagittal slices are denoted by vertical lines. CNV, copy number variation.
Figure 3. The effect of the CNV carrier status (deletion, PopCtrl, duplication) on white matter volume change. The T-scores for the CNV carrier
status are displayed where ﬁndings are highlighted in red or blue if Po0.001 with red indicating less white matter volume for the 15q11.2
(BP1–BP2) deletion carriers, and blue indicating greater volume. The ﬁrst ﬁve images are axial slices (inferior to superior). The rightmost image
shows the locations of the axial slices on a sagittal view. CNV, copy number variation.
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was correct or not. The equations were either correct (C), incorrect
(NC) or false (F).
The 15q11.2(BP1–-BP2) deletion carriers have less C vs F
contrast in the left angular gyrus (Figure 4, Table 1). It has been
proposed that the left angular gyrus supports the retrieval of
mathematical facts such as the multiplication table24 and also the
usage of previously learned facts.25
Correlations between the brain imaging and the cognitive
phenotypes
The Pearson’s correlation measure between each of the cognitive
tests/questionnaire scores in Figure 1 and the brain imaging
phenotypes in Table 1 for both the NoCNV group and the 15q11.2
(BP1–BP2) deletion group was computed (Supplementary Tables 6
and 8). There are signiﬁcant correlations within the cognitive tests/
questionnaire scores and also within the brain imaging pheno-
types. But no signiﬁcant correlation between the brain imaging
phenotypes and the cognitive tests/questionnaire scores. The
failure to detect signiﬁcant association between the cognitive
tests/questionnaire scores and the brain imaging phenotypes
could, at least in part, be explained by the loss of statistical power
due to lower sample size for the intersection of the cognitive
tests/questionnaire scores and brain phenotypes than for them
separately (Supplementary Tables 7 and 9).
DISCUSSION
It has been argued that a complex set of impairments in brain
function account for comorbidity of DLX and DC.6 Here we
demonstrate that the same variant confers risk of both DLX and
DC. It is, however, important to keep in mind that this variant
encompasses several genes. Haploinsufﬁciency of the genes
affected by the 15q11.2(BP1–BP2) deletion impacts both cognitive
traits and brain structure in a pattern consistent with the
cognitive, structural and functional correlates of DLX and DC.
The results show that the cognitive proﬁle of the subjects
carrying the 15q11.2(BP1–BP2) deletion resembles the cognitive
proﬁle of the DLX&DC subjects and, even after correcting for IQ,
associates with the ARHQ and AMHQ scores. As the neuropsycho-
logical proﬁles of the DLXonly and DConly groups are clearly
different and only when combined produce the impairments in
the DLX&DC phenotype, it can be inferred that impairments in
DLX and DC are additive, suggesting that the cognitive processes
involved in DLX and DC are largely independent. However, the
DLX and the DC phenotypes are clearly not independent since
that would mean (assuming 7% prevalence rate of DLX and DC)
that the prevalence of the comorbid phenotype would be 0.49%,
which is not the case. This indicates that some unknown factor
affects both the DLX and the DC cognitive processes in the
DLX&DC phenotype. The neuroimaging data show that the
15q11.2(BP1–BP2) deletion affects both gray and white matter
structures in the brain and is associated with speciﬁc changes in
function relative to controls. In particular, the deletion affects the
left fusiform gyrus and the left angular gyrus, brain structures that
have been associated with both DLX and DC.
The lower GM volume in the left fusiform gyrus of the deletion
carriers is of particular interest as it has been reported that this
region has a major role in reading and mathematical processing.26
The fusiform gyrus is a part of the ventral temporal cortex,27 and is
generally thought to be a key structure for high-level visual
processing including face perception,28 reading29 and object
recognition.30 Alterations in this region have also been associated
with DLX in both structural,31–33 and functional studies,21,34,35 as
well as with DC36 in morphometry and tractography studies. A
recent meta-analysis of brain dysfunction in both DLX children
and adults noted that the fusiform gyrus was the only brain region
affected in both the groups.24
The decreased WM volume observed in the temporal lobe and
cerebellum, and the greater WM volume in the corpus callosum
replicate previous ﬁndings.11,37 Overall, we note that the WM
ﬁndings are stronger than the GM ﬁndings.
As the left fusiform gyrus is thought to support skilled and ﬂuid
reading, and the left angular gyrus to support retrieval of
mathematical facts such as the multiplication table, the structural
and functional alterations in those areas may be the cause of the
speciﬁc learning disorders found in the deletion carriers as some
abnormalities predate literacy38 and numeracy, but may also
reﬂect a lack of reorganization due to emerging literacy39,40 and/
or numeracy. Although caudate GM volume alterations in DLX
have been described previously,41 the interaction with gender is a
novel ﬁnding and may reﬂect differences in articulatory
compensation.42 The ﬁnding of decreased WM in the cerebellum
could lend support to the cerebellar deﬁcit theory,43 which states
that dyslexia is characterized by a general cerebellar abnormality
resulting in impaired ability to perform tasks automatically thereby
negatively affecting language and reading. Overall, the data
support that the 15q11.2(BP1–BP2) CNV maps to a multifocal
neurobiological proﬁle and the implicated structures ﬁt well with
those identiﬁed in studies on reading and/or math problems.
The 15q11.2(BP1–BP2) CNV shows an allele dose-dependent
(mirrored) effect on both the structure and function of the human
brain, that is, duplication carriers show reciprocal changes in
exactly the same brain regions as the deletion. However, this was
not observed for the cognitive traits. Although the deletion
negatively impacts performance on cognitive tests, the duplica-
tion carriers performed on par with controls. A similar asymmetry
between neuroimaging and cognitive phenotypes have been
reported44,45 for the 16p11.2 CNV where the cognitive perfor-
mance is negatively impacted by both the deletion and the
reciprocal duplication.
The BP1–BP2 region, spanning approximately 500 kb, contains
four highly conserved, non-imprinted genes: TUBGCP5, NIPA1,
NIPA2 and CYFIP1. NIPA1, NIPA2 and CYFIP1 are highly expressed
Figure 4. Carrier status-dependent functional difference. (a) The word experiment. A sagittal slice (left), x=− 28, showing the location,
MNI= (−28, − 36, − 14) of signiﬁcant carrier status effect on the contrast PW vs W. (b) The multiplication experiment. A sagittal slice (left),
x=− 50, showing the location, MNI= (−50, − 66, 24), of signiﬁcant carrier status effect on the contrast C vs F. The right images on both a and b
show the location of the sagittal slice on a coronal view. C, correct equation; F, false equation; MNI, Montreal Neurological Institute; PW,
phonologically and orthographically unfamiliar forms; W, orthographic familiar forms of Icelandic nouns.
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widely in the central nervous system, while TUBGCP5 is highly
expressed in the subthalamic nucleus.46 Yoon et al.46 took a
multifaceted approach to investigate why the 15q11.2(BP1–BP2)
deletion confers risk of neuropsychiatric disorders. They used
human iPSC-derived neural progenitors carrying the deletion and
noticed deﬁcits in adherens junctions and apical polarity. They
claim that these results from haploinsufﬁciency of CYFIP1
encoding a subunit of the WAVE complex. They also
demonstrated that in the developing mouse cortex, deﬁciency
in CYFIP1 and WAVE signaling similarly affects radial glial cells,
leading to their ectopic localization outside of the ventricular
zone.46 Bozdagi et al.47 furthermore reported that haploinsufﬁency
of CYFIP1 produces fragile X-like phenotypes in mice. Thus,
haploinsufﬁency of CYFIP1 may contribute to the neuro-
developmental origins of the disorders associated with the
15q11.2(BP1–BP2) deletion.10,46,48
This study adds to the emerging understanding of the impact
conferred by the 15q11.2(BP1–BP2) deletion on brain structure
and function. The deletion confers high risk of the DLX&DC
phenotype (odds ratio = 4.4, P= 1.4 × 10− 4), and the results
demonstrate signiﬁcant volume changes in WM and GM brain
structures in addition to a decrease in brain activation in regions
important for reading and arithmetic. Overall, our ﬁndings shed
light on the role of this CNV in typical and atypical brain
development. The deletion allele impacts cognitive function and
learning and is probably the strongest factor contributing to the
DLX&DC phenotype in the affected carriers.
Brain structure is largely shaped by sequence variants that exert
lasting inﬂuences on its function and several common variants
have been associated with subcortical structures.49,50 The
conﬂuence of common variants predicting subcortical structures
does, however, not predispose to brain diseases like
schizophrenia.51 Thus, although brain structure volumes show
high heritability, there may not be a direct correlation with
diseases. Hence, although subcortical volumes may differentiate
patients from controls, the explanation may not necessarily be
rooted in their genomes. Many brain disorders are heterogeneous
groups of disorders at the level of genetic etiology and clinical
presentation. Through high-impact variants, the relationship
between genotype and phenotype may be disentangled, which,
in turn, may help determine which brain phenotypes, associated
with a disease, are a cause or consequence of the disease. For
instance, larger putamen and pallidum volumes associate with
duration of illness in schizophrenia,51 a consequence of the
disease that can be combatted with antipsychotic drugs.
Here we have demonstrated by using convergent evidence
from neuropsychological testing and structural and functional
neuroimaging that a high-impact sequence variant provides
insight into the causes of variability in human brain structure
and function. Although the 15q11.2 CNV alleles confer mirror
effects on both brain structure and function, only the deletion
affects cognition with large effect. Sequence variants inﬂuencing
brain structures may reveal new biological mechanisms under-
lying cognition and neuropsychiatric illness.
CONFLICT OF INTEREST
MOU, GBW, OG, SS, DFG, SA, GAJ, RSG, GB, HH, BS, LJ, VKE, GRE, GHJ, UU, PS, UT, HS
and KS are employees of deCode genetics/Amgen. BJ is an employee of Röntgen
domus. The remaining authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
We are grateful to the participants and we thank the nurses and staff at the Research
Recruitment Center and technicians and staff at Röntgen Domus (in particular
Gunnhildur Sigurdardottir). We also thank the staff at deCODE genetics core facilities
and all our colleagues for their important contribution to this work. We also
acknowledge Eirikur Rognvaldsson (Professor of Icelandic Language and Linguistics
at the University of Iceland) for his assistance in selecting Icelandic words for the
lexical decision task. The research leading to these results has received support from
the Innovative Medicines Initiative Joint Undertaking under grant agreements’ no.
115008 (NEWMEDS) and no. 115300 (EUAIMS) of which resources are composed of
EFPIA in-kind contribution and ﬁnancial contribution from the European Union’s
Seventh Framework Programme (EU-FP7/2007-2013), EU-FP7 funded grant no.
602450 (IMAGEMEND) and EU funded FP7-People-2011-IAPP grant agreement no.
286213 (PsychDPC). Approval for this study was obtained from the National Bioethics
Committee of Iceland and the Icelandic Data Protection Authority.
REFERENCES
1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental
Disorders (DSM5), vol. 5. American Psychiatric Publishing: Arlington, VA, USA, 2013.
2 Plomin R, Kovas Y. Generalist genes and learning disabilities. Psychol Bull 2005;
131: 592–617.
3 Bishop DV. The interface between genetics and psychology: lessons from
developmental dyslexia. Proc Biol Sci 2015; 282: 20143139.
4 Pettigrew KA, Fajutrao Valles SF, Moll K, Northstone K, Ring S, Pennell C et al.
Lack of replication for the myosin-18B association with mathematical ability in
independent cohorts. Genes Brain Behav 2015; 14: 369–376.
5 Landerl K, Fussenegger B, Moll K, Willburger E. Dyslexia and dyscalculia: two
learning disorders with different cognitive proﬁles. J Exp Child Psychol 2009; 103:
309–324.
6 Wilson AJ, Andrewes SG, Struthers H, Rowe VM, Bogdanovic R, Waldie KE.
Dyscalculia and dyslexia in adults: cognitive bases of comorbidity. Learn Individ
Differ 2015; 37: 118–132.
7 Clark D. The Brain and Behavior. Cambridge University Press: Cambridge, 2005.
8 Seghier ML. The angular gyrus: multiple functions and multiple subdivisions.
Neuroscientist 2013; 19: 43–61.
9 Grabner RH, Ischebeck A, Reishofer G, Koschutnig K, Delazer M, Ebner F et al. Fact
learning in complex arithmetic and ﬁgural-spatial tasks: the role of the angular
gyrus and its relation to mathematical competence. Hum Brain Mapp 2009; 30:
2936–2952.
10 Rosenfeld JA, Coe BP, Eichler EE, Cuckle H, Shaffer LG. Estimates of penetrance for
recurrent pathogenic copy-number variations. Genet Med 2013; 15: 478–481.
11 Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K,
Arnarsdottir S et al. CNVs conferring risk of autism or schizophrenia affect
cognition in controls. Nature 2014; 505: 361–366.
12 Singh T, Walters JTR, Johnstone M, Curtis D, Suvisaari J, Torniainen M et al. Rare
schizophrenia risk variants are enriched in genes shared with neuro-
developmental disorders. bioRxiv 2016.
13 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The
Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and
validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
J Clin Psychiatry 1998; 20 (59 Suppl): 22–33.
14 Bjornsdottir G, Halldorsson JG, Steinberg S, Hansdottir I, Kristjansson K, Stefansson
H et al. The Adult Reading History Questionnaire (ARHQ) in Icelandic: psycho-
metric properties and factor structure. J Learn Disabil 2014; 47: 532–542.
15 Wright IC, McGuire PK, Poline JB, Travere JM, Murray RM, Frith CD et al. A voxel-
based method for the statistical analysis of gray and white matter density applied
to schizophrenia. Neuroimage 1995; 2: 244–252.
16 Ashburner J, Friston KJ. Voxel-based morphometry—the methods. Neuroimage
2000; 11(6 Pt 1): 805–821.
17 Evans AC, Collins DL, Mills SR, Brown ED, Kelly RL, Peters TM. 3D statistical neuro-
anatomical models from 305 MRI volumes. Proceedings of the Nuclear Science
Symposium and Medical Imaging Conference, 1993. 1993 IEEE Conference Record,
31 October–6 November 1993.
18 Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;
38: 95–113.
19 Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuro-
imaging: a comparative review. Stat Methods Med Res 2003; 12: 419–446.
20 Cao J, Worsley KJ. Applications of random ﬁelds in human brain mapping.
In: Spatial Statistics: Methodological Aspects and Applications, vol. 159.
Springer-Verlag: New York, 2001, pp 170–182.
21 van der Mark S, Bucher K, Maurer U, Schulz E, Brem S, Buckelmuller J et al.
Children with dyslexia lack multiple specializations along the visual word-form
(VWF) system. Neuroimage 2009; 47: 1940–1949.
22 Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N
et al. Automated anatomical labeling of activations in SPM using a macroscopic
anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15:
273–289.
23 Volz KG, Schubotz RI, von Cramon DY. Variants of uncertainty in decision-making
and their neural correlates. Brain Res Bull 2005; 67: 403–412.
Impact of 15q11.2 CNV on dyslexia and dyscalculia
MO Ulfarsson et al
7
Translational Psychiatry (2017), 1 – 8
24 Dehaene S, Piazza M, Pinel P, Cohen L. Three parietal circuits for number pro-
cessing. Cogn Neuropsychol 2003; 20: 487–506.
25 Ischebeck A, Zamarian L, Schocke M, Delazer M. Flexible transfer of knowledge in
mental arithmetic—an fMRI study. Neuroimage 2009; 44: 1103–1112.
26 Butterworth B, Varma S, Laurillard D. Dyscalculia: from brain to education. Science
2011; 332: 1049–1053.
27 Weiner KS, Zilles K. The anatomical and functional specialization of the
fusiform gyrus. Neuropsychologia 2015; 83: 48–62.
28 Kanwisher N, McDermott J, Chun MM. The fusiform face area: a module in human
extrastriate cortex specialized for face perception. J Neurosci 1997; 17: 4302–4311.
29 Cohen L, Dehaene S, Naccache L, Lehericy S, Dehaene-Lambertz G, Henaff MA
et al. The visual word form area: spatial and temporal characterization of an initial
stage of reading in normal subjects and posterior split-brain patients. Brain 2000;
123(Pt 2): 291–307.
30 Grill-Spector K, Kourtzi Z, Kanwisher N. The lateral occipital complex and its role in
object recognition. Vision Res 2001; 41: 1409–1422.
31 Richlan F, Kronbichler M, Wimmer H. Structural abnormalities in the dyslexic brain:
a meta-analysis of voxel-based morphometry studies. Hum Brain Mapp 2013; 34:
3055–3065.
32 Linkersdorfer J, Lonnemann J, Lindberg S, Hasselhorn M, Fiebach CJ. Grey matter
alterations co-localize with functional abnormalities in developmental dyslexia: an
ALE meta-analysis. PLoS ONE 2012; 7: e43122.
33 Kronbichler M, Wimmer H, Staffen W, Hutzler F, Mair A, Ladurner G. Develop-
mental dyslexia: gray matter abnormalities in the occipitotemporal cortex. Hum
Brain Mapp 2008; 29: 613–625.
34 Maisog JM, Einbinder ER, Flowers DL, Turkeltaub PE, Eden GF. A meta-analysis of
functional neuroimaging studies of dyslexia. Ann N Y Acad Sci 2008; 1145:
237–259.
35 Richlan F, Kronbichler M, Wimmer H. Functional abnormalities in the dyslexic
brain: a quantitative meta-analysis of neuroimaging studies. Hum Brain Mapp
2009; 30: 3299–3308.
36 Rykhlevskaia E, Uddin LQ, Kondos L, Menon V. Neuroanatomical correlates of
developmental dyscalculia: combined evidence from morphometry and tracto-
graphy. Front Hum Neurosci 2009; 3: 51.
37 Ashkenazi S, Black JM, Abrams DA, Hoeft F, Menon V. Neurobiological under-
pinnings of math and reading learning disabilities. J Learn Disabil 2013; 46:
549–569.
38 Raschle NM, Chang M, Gaab N. Structural brain alterations associated with dys-
lexia predate reading onset. Neuroimage 2011; 57: 742–749.
39 Brem S, Bach S, Kucian K, Guttorm TK, Martin E, Lyytinen H et al. Brain sensitivity
to print emerges when children learn letter-speech sound correspondences. Proc
Natl Acad Sci USA 2010; 107: 7939–7944.
40 Dehaene S, Cohen L, Morais J, Kolinsky R. Illiterate to literate: behavioural and
cerebral changes induced by reading acquisition. Nat Rev Neurosci 2015; 16:
234–244.
41 Brown WE, Eliez S, Menon V, Rumsey JM, White CD, Reiss AL. Preliminary evidence
of widespread morphological variations of the brain in dyslexia. Neurology 2001;
56: 781–783.
42 Wimmer H, Schurz M, Sturm D, Richlan F, Klackl J, Kronbichler M et al. A dual-route
perspective on poor reading in a regular orthography: an fMRI study. Cortex 2010;
46: 1284–1298.
43 Nicolson RI, Fawcett AJ, Dean P. Developmental dyslexia: the cerebellar deﬁcit
hypothesis. Trends Neurosci 2001; 24: 508–511.
44 Maillard AM, Ruef A, Pizzagalli F, Migliavacca E, Hippolyte L, Adaszewski S et al.
The 16p11.2 locus modulates brain structures common to autism, schizophrenia
and obesity. Mol Psychiatry 2015; 20: 140–147.
45 Qureshi AY, Mueller S, Snyder AZ, Mukherjee P, Berman JI, Roberts TP et al.
Opposing brain differences in 16p11.2 deletion and duplication carriers. J Neurosci
2014; 34: 11199–11211.
46 Yoon KJ, Nguyen HN, Ursini G, Zhang F, Kim NS, Wen Z et al. Modeling a genetic
risk for schizophrenia in iPSCs and mice reveals neural stem cell deﬁcits asso-
ciated with adherens junctions and polarity. Cell Stem Cell 2014; 15: 79–91.
47 Bozdagi O, Sakurai T, Dorr N, Pilorge M, Takahashi N, Buxbaum JD. Haploinsufﬁ-
ciency of Cyﬁp1 produces fragile X-like phenotypes in mice. PLoS ONE 2012; 7:
e42422.
48 Pathania M, Davenport EC, Muir J, Sheehan DF, Lopez-Domenech G, Kittler JT. The
autism and schizophrenia associated gene CYFIP1 is critical for the maintenance
of dendritic complexity and the stabilization of mature spines. Transl Psychiatry
2014; 4: e374.
49 Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM et al.
Identiﬁcation of common variants associated with human hippocampal and
intracranial volumes. Nat Genet 2012; 44: 552–561.
50 Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N et al.
Common genetic variants inﬂuence human subcortical brain structures. Nature
2015; 520: 224–229.
51 Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJ et al. Genetic
inﬂuences on schizophrenia and subcortical brain volumes: large-scale proof of
concept. Nat Neurosci 2016; 19: 420–431.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
© The Author(s) 2017
Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)
Impact of 15q11.2 CNV on dyslexia and dyscalculia
MO Ulfarsson et al
8
Translational Psychiatry (2017), 1 – 8
